Mono-Methyl-Histone H3 (Lys18) Antibody

What is Mono-Methyl-Histone H3 (Lys18) and what is its biological significance?

Mono-Methyl-Histone H3 (Lys18) (H3K18me1) is a specific post-translational modification where the lysine 18 residue on histone H3 is monomethylated. Histone H3 is one of the four core histones that make up the nucleosome core particle, the basic structural unit of chromatin. Histone methylation is a dynamic process that plays a crucial role in controlling chromatin structure and gene accessibility . While extensive research has characterized the roles of acetylation at this position, the specific functions of H3K18 monomethylation in transcriptional regulation and its genome-wide distribution patterns continue to be investigated. The modification status at K18 contributes to the broader epigenetic code that regulates gene expression patterns.

What applications can Mono-Methyl-Histone H3 (Lys18) antibodies be used for?

Mono-Methyl-Histone H3 (Lys18) antibodies are versatile research tools suitable for multiple applications:

Certain antibody clones may also be suitable for Chromatin Immunoprecipitation (ChIP) applications, though validation is essential for this specific use case.

What is the specificity profile of high-quality Mono-Methyl-Histone H3 (Lys18) antibodies?

High-quality H3K18me1 antibodies demonstrate strict specificity for their target modification. For example, clone RM167 (a widely used monoclonal antibody):

• Specifically recognizes histone H3 monomethylated at Lysine 18 (K18me1)

• Shows no cross-reactivity with non-modified Lysine 18 (K18)

• Shows no cross-reactivity with dimethylated Lysine 18 (K18me2)

• Shows no cross-reactivity with trimethylated Lysine 18 (K18me3)

• Shows no cross-reactivity with other methylation marks on histone H3

This specificity has been verified through Western blot analysis, typically showing a single band at approximately 15-17 kDa corresponding to histone H3 in acid extracts of cells such as HeLa .

What storage conditions maintain optimal antibody activity?

To maintain optimal antibody performance and stability:

• Store at -20°C for long-term storage

• Antibodies are typically supplied in liquid form containing:

  • 50% Glycerol/PBS buffer

  • 1% BSA as a stabilizer

  • 0.09% sodium azide as a preservative

• Stability: Typically guaranteed for 1 year when properly stored

• Avoid repeated freeze-thaw cycles as this can denature the antibody

• For repeated access, aliquot the antibody before freezing

Which species does the Mono-Methyl-Histone H3 (Lys18) antibody react with?

Species reactivity varies slightly between different antibody clones, but generally includes:

• Human: Validated reactivity in most products

• Mouse: Validated reactivity in most products

• Rat: Validated for some products

• Vertebrates (broadly): Expected reactivity for many antibodies

Based on sequence homology analysis, some antibodies may also work with samples from:

• C. elegans

• Chicken

• Xenopus

• Drosophila

• Plants

Always check the specific product documentation for validated species reactivity.

How does H3K18 monomethylation interact with other histone modifications?

The modification status at H3K18 appears to participate in histone modification crosstalk networks. Recent research has revealed interesting relationships between modifications at this position:

• H3K18 acetylation (H3K18ac) has a pronounced stimulatory effect on MLL1-mediated H3K4 methylation, suggesting that the modification state of K18 can influence modifications at other positions

• Middle-down mass spectrometry has shown preferential co-enrichment of H3K4me1 and H3K4me3 with H3 N-terminal tail proteoforms bearing the dual modification H3{K18acK23ac}

• Since methylation and acetylation are mutually exclusive on the same lysine residue, H3K18me1 likely functions within a regulatory network that modulates accessibility to acetyltransferases and deacetylases

• The methylation at K18 may serve as a recognition site for specific reader proteins that consequently influence surrounding chromatin architecture

This suggests that the monomethylation state of H3K18 may be part of a broader "histone code" that coordinates with other modifications to regulate chromatin structure and gene expression.

What are optimal protocols for Western blot detection using Mono-Methyl-Histone H3 (Lys18) antibodies?

For optimal Western blot results:

Sample Preparation:

• Prepare acid extracts of cells or tissues (commonly used for histone extraction)

• Alternatively, use purified histones or recombinant H3 with defined modifications

Protocol:

• Load 10-20 μg of histone-enriched extract per lane

• Separate proteins on 15% SDS-PAGE gels (optimal for small histone proteins)

• Transfer to PVDF membrane (recommended over nitrocellulose for small proteins)

• Block with 5% non-fat milk or BSA in TBST

• Incubate with primary antibody (1-2 μg/mL) overnight at 4°C

• Wash thoroughly with TBST (3-5 times, 5 minutes each)

• Incubate with appropriate secondary antibody (typically goat anti-rabbit IgG conjugated to HRP)

• Visualize using enhanced chemiluminescence detection system

Expected Results:

• A single specific band at approximately 15-17 kDa corresponding to histone H3

• When testing with recombinant histone H3.3 and HeLa cell extracts, a clear band should be visible in samples containing the H3K18me1 modification

How should proper validation of Mono-Methyl-Histone H3 (Lys18) antibody specificity be performed?

Comprehensive antibody validation includes:

• Peptide Arrays/Competition Assays:

  • Test antibody against a panel of histone peptides with various modifications

  • Include unmodified, monomethylated, dimethylated, and trimethylated K18 peptides

  • Confirm binding only to the K18me1 peptide

• Western Blot Validation:

  • Test against recombinant histone H3 with defined modifications

  • Verify single band at expected molecular weight (~15-17 kDa)

  • Include histone extracts from cells with known H3K18me1 status

• Dot Blot Specificity Analysis:

  • Spot various modified peptides at different concentrations

  • Confirm signal only with K18me1 peptides

• Mass Spectrometry Correlation:

  • Compare antibody-based detection with mass spectrometry quantification

  • Validate using middle-down mass spectrometry approaches to confirm specificity

• Genetic Controls:

  • Ideally, test in cells with genetic knockdown/knockout of the methyltransferase responsible for K18 monomethylation

  • Compare with wild-type cells to confirm specificity

What are the key differences between monoclonal and polyclonal antibodies targeting H3K18me1?

For applications requiring the highest specificity (such as ChIP-seq), monoclonal antibodies are often preferred, while polyclonal antibodies may provide advantages in applications requiring stronger signal amplification.

How does the functional role of H3K18 monomethylation compare to H3K18 acetylation?

While both modifications occur on the same amino acid residue, they have distinct functional implications:

• H3K18 Acetylation:

  • Associated with active gene transcription

  • Stimulates MLL1-mediated H3K4 methylation

  • Often found at promoter regions of actively transcribed genes

  • Creates a permissive chromatin environment

• H3K18 Monomethylation:

  • Functionally distinct from acetylation (they are mutually exclusive on the same residue)

  • May function as a transitional state in chromatin regulation

  • Could potentially serve to prevent acetylation at this position, indirectly regulating H3K4 methylation

  • Likely recruits different reader proteins than H3K18ac

Recent studies highlight that "site-specific acetylation states differentially influence the activity of MLL1 in vitro, with a pronounced stimulation by H3K18ac and H3K23ac" . This suggests that the methylation status at K18 may be part of complex regulatory mechanisms controlling gene expression.

What experimental controls should be included when using Mono-Methyl-Histone H3 (Lys18) antibody?

For robust experimental design, include:

Positive Controls:

• Recombinant histone H3 with verified K18me1 modification

• Cell lines known to have high levels of H3K18me1

• Synthetic K18me1 peptides

Negative Controls:

• Unmodified histone H3

• Histone H3 with other methylation states at K18 (K18me2, K18me3)

• Peptide competition assay using the immunizing peptide

• Samples treated with demethylase enzymes

Technical Controls:

• Loading controls for western blots (total histone H3)

• No primary antibody control for immunofluorescence

• IgG control for ChIP experiments

• Isotype-matched control antibodies

Proper controls ensure that observed signals are specific to the H3K18me1 modification rather than experimental artifacts or cross-reactivity.

How can I investigate the relationship between H3K18me1 and other histone marks?

To study the functional relationship between H3K18me1 and other modifications:

• Sequential ChIP (ChIP-reChIP):

  • First ChIP with H3K18me1 antibody

  • Second ChIP with antibodies against other modifications

  • Identifies genomic regions containing both modifications

• Mass Spectrometry Analysis:

  • Apply "middle-down mass spectrometry" approaches to quantify co-occurrence of modifications

  • Analyze combinatorial patterns of modifications on the same histone tail

• Comparative ChIP-seq:

  • Perform ChIP-seq with H3K18me1 antibody

  • Compare with existing datasets for other histone marks

  • Identify regions of overlap and exclusion

• In Vitro Binding Assays:

  • Use recombinant proteins with reader domains

  • Test binding to nucleosomes with different modification combinations

  • Similar to the approach described for methylation assays in

• Functional Genomics:

  • Manipulate enzymes responsible for H3K18me1 deposition

  • Assess impact on other histone modifications

  • Analyze resulting changes in gene expression

How can I optimize ChIP-seq experiments using Mono-Methyl-Histone H3 (Lys18) antibody?

For successful ChIP-seq experiments:

Pre-Experiment Validation:

• Verify antibody specificity using peptide arrays or dot blots

• Perform ChIP-qPCR on known regions to confirm enrichment

• Test multiple antibody concentrations to determine optimal amount

Experimental Protocol:

• Crosslink cells with 1% formaldehyde (10 minutes at room temperature)

• Sonicate chromatin to 200-500 bp fragments

• Use 2-5 μg of antibody per ChIP reaction

• Include input control and IgG control

• Perform stringent washes to reduce background

• Prepare libraries following standard protocols

Data Analysis Considerations:

• Use appropriate peak calling algorithms (e.g., MACS2)

• Compare with datasets for other histone modifications

• Correlate with gene expression data

• Analyze enrichment at specific genomic features (promoters, enhancers, etc.)

• Consider integrating with RNA-seq or ATAC-seq data for comprehensive chromatin state analysis

Potential Challenges:

• Low abundance of H3K18me1 may require optimized immunoprecipitation conditions

• Highly specific antibodies like RM167 are crucial for accurate results

• Consider using spike-in controls for quantitative comparisons across samples

What methods can be used for quantitative analysis of H3K18me1 levels?

Several approaches enable quantitative assessment of H3K18me1:

• Histone Extraction and Western Blot:

  • Extract histones using acid extraction method

  • Quantify against standard curves

  • Normalize to total H3 levels

  • Provides global level assessment

• Mass Spectrometry Approaches:

  • "Middle-down mass spectrometry" for precise quantification

  • Allows detection of combinatorial modifications

  • Can use parallel reaction monitoring (PRM) for targeted analysis

  • Provides absolute quantification of modification levels

• ELISA-Based Quantification:

  • Use validated antibodies at 0.2-1 μg/mL concentration

  • Develop standard curves with modified peptides

  • Allows high-throughput screening

• Luminex/Multiplex Assays:

  • Enable simultaneous quantification of multiple histone modifications

  • Require careful antibody validation to prevent cross-reactivity

  • Recommended antibody concentration: 0.1-0.5 μg/mL

• Fluorescence Polarization (FP) Assays:

  • Similar to approaches described for methyl-lysine binding assays

  • Can measure interaction kinetics and binding affinities

  • Provides homogeneous detection without washing steps

How should I prepare samples for optimal detection of H3K18me1?

Sample preparation is critical for accurate detection:

For Cell/Tissue Lysates:

• Use fresh or properly stored frozen samples

• Extract histones using acid extraction:

  • Lyse cells in hypotonic buffer

  • Extract histones with 0.2N HCl or 0.4N H2SO4

  • Precipitate with trichloroacetic acid (TCA)

  • Wash precipitate with acetone

  • Resuspend in appropriate buffer

For Western Blotting:

• Denature histones in sample buffer containing SDS

• Use 15-18% polyacrylamide gels for optimal separation

• Include reducing agent (e.g., β-mercaptoethanol)

• Transfer at low voltage (30V) overnight for efficient transfer of small proteins

For ChIP Experiments:

• Crosslink with 1% formaldehyde (10 minutes at room temperature)

• Quench with 125 mM glycine

• Isolate nuclei before sonication

• Optimize sonication conditions to generate 200-500 bp fragments

• Pre-clear chromatin with protein A/G beads before immunoprecipitation

For Immunofluorescence:

• Fix cells with 4% paraformaldehyde

• Permeabilize with 0.1% Triton X-100

• Include antigen retrieval step (may improve detection)

• Block thoroughly to reduce background

• Use optimized antibody concentration

Proper sample preparation ensures optimal detection sensitivity and specificity across different experimental platforms.